BFS
PRCT icon

Bare Financial Services’s Procept Biorobotics PRCT Stock Holding History

Bare Financial Services’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-36
Closed -$900 – 1889
2026
Q1 		$900 Sell
36
-5
-12% -$141 ﹤0.01% 1300
2025
Q4 		$1.29K Buy
41
+28
+215% +$929 ﹤0.01% 1023
2025
Q3 		$464 Buy
+13
New +$594 ﹤0.01% 1339

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bare Financial Services's PRCT Position: Q2 2026 in Review

Bare Financial Services sold out of Procept Biorobotics (PRCT) in Q2 2026, closing a stake of 36 shares — an estimated $900 sold.

Bare Financial Services first reported a position in PRCT in Q3 2025 and held it in 3 quarters. The position peaked at $1.29K in Q4 2025. 253 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Bare Financial Services reported no remaining Procept Biorobotics position as of Q2 2026 after selling out during the quarter.
  • Bare Financial Services sold 36 Procept Biorobotics shares in Q2 2026, an estimated $900.
  • Bare Financial Services first reported a position in Procept Biorobotics in Q3 2025 and held it in 3 quarters.
  • Bare Financial Services's Procept Biorobotics position peaked at $1.29K in Q4 2025.
  • 253 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Bare Financial Services's 13F filing for Q2 2026, filed 27 Jul 2026.